A Systematic Review of Sorafenib in Child-Pugh A Patients With Unresectable Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Systematic Review of Sorafenib in Child-Pugh A Patients With Unresectable Hepatocellular Carcinoma

Published:2013-11 Issue:10 Volume:47 Page:871-880
ISSN:0192-0790
Container-title:Journal of Clinical Gastroenterology
language:en
Short-container-title:

Author:

Shen Ai,Tang Chengyong,Wang Yefei,Chen Yong,Yan Xiong,Zhang Chao,Liu Rui,Wei Xufu,Zhu Yiyun,Zhang Hua,Wu Zhongjun

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference11 articles.

1. Management of hepatocellular carcinoma: an update.;Bruix;Hepatology,2011

2. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival.;Llovet;Hepatology,2003

3. Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials.;Je;Lancet Oncol,2009

4. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints.;Parmar;Stat Med,1998

5. Random-effects model for meta-analysis of clinical trials: an update.;DerSimonian;Contemp Clin Trials,2007

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overexpression of the lncRNA HOTAIRM1 promotes lenvatinib resistance by downregulating miR-34a and activating autophagy in hepatocellular carcinoma;Discover Oncology;2023-05-12

2. Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma;Biomedicines;2022-09-14

3. Early predictive value of circulating biomarkers for sorafenib in advanced hepatocellular carcinoma;Expert Review of Molecular Diagnostics;2022-03-04

4. The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab;Cancers;2022-01-11

5. Efficacy of First Line Systemic Chemotherapy and Multikinase Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis;Frontiers in Oncology;2021-03-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3